SwePub
Sök i LIBRIS databas

  Extended search

onr:"swepub:oai:DiVA.org:uu-238753"
 

Search: onr:"swepub:oai:DiVA.org:uu-238753" > Alternative lengthe...

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Alternative lengthening of telomerases is enriched in, and impacts survival of TP53 mutant pediatric malignant brain tumors

Mangerel, Joshua (author)
Price, Aryeh (author)
Castelo-Branco, Pedro (author)
show more...
Brzezinski, Jack (author)
Buczkowicz, Pawel (author)
Rakopoulos, Patricia (author)
Merino, Diana (author)
Baskin, Berivan (author)
Uppsala universitet,Medicinsk genetik
Wasserman, Jonathan (author)
Mistry, Matthew (author)
Barszczyk, Mark (author)
Picard, Daniel (author)
Mack, Stephen (author)
Remke, Marc (author)
Starkman, Hava (author)
Elizabeth, Cynthia (author)
Zhang, Cindy (author)
Alon, Noa (author)
Lees, Jodi (author)
Andrulis, Irene L. (author)
Wunder, Jay S. (author)
Jabado, Nada (author)
Johnston, Donna L. (author)
Rutka, James T. (author)
Dirks, Peter B. (author)
Bouffet, Eric (author)
Taylor, Michael D. (author)
Huang, Annie (author)
Malkin, David (author)
Hawkins, Cynthia (author)
Tabori, Uri (author)
show less...
 (creator_code:org_t)
2014-10-15
2014
English.
In: Acta Neuropathologica. - : Springer Science and Business Media LLC. - 0001-6322 .- 1432-0533. ; 128:6, s. 853-862
Related links:
https://urn.kb.se/re...
show more...
https://doi.org/10.1...
show less...
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Although telomeres are maintained in most cancers by telomerase activation, a subset of tumors utilize alternative lengthening of telomeres (ALT) to sustain self-renewal capacity. In order to study the prevalence and significance of ALT in childhood brain tumors we screened 517 pediatric brain tumors using the novel C-circle assay. We examined the association of ALT with alterations in genes found to segregate with specific histological phenotypes and with clinical outcome. ALT was detected almost exclusively in malignant tumors (p = 0.001). ALT was highly enriched in primitive neuroectodermal tumors (12 %), choroid plexus carcinomas (23 %) and high-grade gliomas (22 %). Furthermore, in contrast to adult gliomas, pediatric low grade gliomas which progressed to high-grade tumors did not exhibit the ALT phenotype. Somatic but not germline TP53 mutations were highly associated with ALT (p = 1.01 × 10(-8)). Of the other alterations examined, only ATRX point mutations and reduced expression were associated with the ALT phenotype (p = 0.0005). Interestingly, ALT attenuated the poor outcome conferred by TP53 mutations in specific pediatric brain tumors. Due to very poor prognosis, one year overall survival was quantified in malignant gliomas, while in children with choroid plexus carcinoma, five year overall survival was investigated. For children with TP53 mutant malignant gliomas, one year overall survival was 63 ± 12 and 23 ± 10 % for ALT positive and negative tumors, respectively (p = 0.03), while for children with TP53 mutant choroid plexus carcinomas, 5 years overall survival was 67 ± 19 and 27 ± 13 % for ALT positive and negative tumors, respectively (p = 0.07). These observations suggest that the presence of ALT is limited to a specific group of childhood brain cancers which harbor somatic TP53 mutations and may influence the outcome of these patients. Analysis of ALT may contribute to risk stratification and targeted therapies to improve outcome for these children.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Keyword

Molekylär medicin
Molecular Medicine

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

  • 1 of 1
  • Previous record
  • Next record
  •    To hitlist

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view